Listado de ensayos


Genotype-Phenotype Study of Patients With Plaquenil – Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Estado: | Categoría: | Resultado:

Patología

Genotype Retinal Disease

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Ver informe

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: MA09-hRPE

Localizaciones

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States Bascom Palmer Eye Institute, Miami, Florida, United States Wills Eye Institute-Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
Ver informe

Study of STG-001 in Subjects With Stargardt Disease

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT-1

Tratamiento

MEDICAMENTO: STG-001

Localizaciones

Associated Retina Consultants, Phoenix, Arizona, United States Vitreo Retinal Associates, P.A., Gainesville, Florida, United States Casey Eye Institute - OHSU, Portland, Oregon, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States Retina Foundation of Southwest, Dallas, Texas, United States
Ver informe

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Greater Baltimore Medical Center, Baltimore, Maryland, United States Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States Retina Foundation of the Southwest, Dallas, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States Institut de la Vision, Paris, France Center for Ophthalmic Research, University of Teubingen, T bingen, Germany Moorfields Eye Hospital, London, United Kingdom
Ver informe

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Wilmer Eye Institute, Baltimore, Maryland, United States Retina Foundation of the Southwest, Dallas, Texas, United States Universit ts-Augenklinik Bonn, Bonn, Germany Center for Opthalmic Research, University of Tuebingen, Tuebingen, Germany Moorfields Eye Hospital, London, United Kingdom
Ver informe

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT 1

Tratamiento

MEDICAMENTO: Zimura Other: Sham

Localizaciones

Retinal Consultants of Arizona, Phoenix, Arizona, United States Jules Stein Eye Institute/ David Geffen School of Medicine, Los Angeles, California, United States VitreoRetinal Associates, Gainesville, Florida, United States Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States Retina Center P.A., Minneapolis, Minnesota, United States Oregon Health & Science University, Portland, Oregon, United States Mid Atlantic Retina, Philadelphia, Pennsylvania, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States and 30 more
Ver informe

Phase I/IIA Study of SAR422459 in Participants With Stargardt’s Macular Degeneration

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: SAR422459

Localizaciones

Investigational Site Number 840002, Miami, Florida, United States Investigational Site Number 840005, Iowa City, Iowa, United States Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 840004, Houston, Texas, United States Investigational Site Number 250001, Paris, France
Ver informe

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: Long term follow up in all patients who received SAR422459 in previous study TDU13583

Localizaciones

Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 250001, Paris, France
Ver informe

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to ENFERMEDAD DE STARGARDT

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT Macular Atrophy

Tratamiento

MEDICAMENTO: Emixustat

Localizaciones

Dallas, Texas, United States
Ver informe

Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and ENFERMEDAD DE STARGARDT

Estado: | Categoría: | Resultado:

Patología

Dry AMD ENFERMEDAD DE STARGARDT 1

Tratamiento

SUPLEMENTO DIETETICO: Madeos SUPLEMENTO DIETETICO: Placebo

Localizaciones

Centre National d'Ophtalmologie des Quinze-Vingts, Paris, France Department of Ophthalmology, Justus-Liebig-University- Giessen, Gie en, Germany Universit degli Studi G. d'Annunzio Chieti-Pescara, Chieti, Italy ASST Santi Paolo e Carlo, Milan, Italy Department of Ophthalmology, University Vita Salute, Milan, Italy
Ver informe